Philipps-Universität Marburg

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia (2021) Stasik S, Eckardt JN, Kramer M, Roellig C, Kraemer A, Scholl S, Hochhaus A, et al. Journal article High Na+ Environments Impair Phagocyte Oxidase-Dependent Antibacterial Activity of Neutrophils (2021) Krampert L, Bauer K, Ebner S, Neubert P, Ossner T, Weigert A, Schatz V, et al. Journal article The contribution of insects to global forest deadwood decomposition (2021) Seibold S, Rammer W, Hothorn T, Seidl R, Ulyshen MD, Lorz J, Cadotte MW, et al. Journal article Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al. Conference contribution Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Kallinich T, Weller-Heinemann F, et al. Conference contribution Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment (2021) Erber R, Hartmann A, Fasching P, Rübner M, Stöhr R, Beckmann M, Zentgraf M, et al. Journal article Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death (2021) Matrood S, De Prisco N, Wissniowski TT, Wiese D, Jabari S, Griesmann H, Wanzel M, et al. Journal article The dry and the wet case: Tree growth response in climatologically contrasting years on the island of corsica (2021) Häusser M, Szymczak S, Knerr I, Bendix J, Garel E, Huneau F, Trachte K, et al. Journal article Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer (2021) Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, et al. Journal article KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution